Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Dini

Showing results (171-180 of 190) with videos related to

Pageof 19
Sort By:
The Journal of Investigative Dermatology|December 30, 2024
Polygenic Score: A Tool for Evaluating the Genetic Background of Sporadic Hidradenitis SuppurativaChiara Moltrasio, Ronald Moura, Andrea Conti, et al.
Dermatology (Basel, Switzerland)|September 2, 2021
Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of DiseaseGabriella Fabbrocini, Giulia Ruina, Giulia Giovanardi, et al.
Dermatology and Therapy|February 16, 2026
Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis)Emanuele Trovato, Alessandra Cartocci, Francesca Gaiani, et al.
Journal of Clinical Medicine|May 28, 2022
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient WellbeingFrancesca Prignano, Alexandra M G Brunasso, Gabriella Fabbrocini, et al.
Dermatology and Therapy|July 3, 2025
Guselkumab Retention, Effectiveness, and Safety in Psoriasis: A 260-Week Real-World Multicenter Retrospective Study Exploring the Role of Concomitant PsA-IL PSO (Italian Landscape Psoriasis)Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
Journal of Cutaneous Medicine and Surgery|March 17, 2026
Long-Term Outcomes of Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa: A Multicentre Cohort StudyGianluca Avallone, Gabriele Roccuzzo, Luca Valtellini, et al.
Clinical and Experimental Dermatology|November 1, 2025
Cumulative clinical benefits of biologic treatments in patients with moderate-to-severe psoriasis: an Italian real-life experience - IL PSO (Italian Landscape Psoriasis)Diego Orsini, Luca Potestio, Maria Concetta Fargnoli, et al.
Dermatology (Basel, Switzerland)|July 14, 2024
Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert PanelAnnamaria Offidani, Angelo Valerio Marzano, Ketty Peris, et al.
Journal of Clinical Medicine|January 11, 2024
Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe PsoriasisFrancesca Prignano, Giuseppe Argenziano, Federico Bardazzi, et al.
Medicina (Kaunas, Lithuania)|February 26, 2025
High-Frequency and Ultra-High-Frequency Ultrasound in Dermatologic Diseases and Aesthetic MedicineGiulio Argalia, Alfonso Reginelli, Elisa Molinelli, et al.
Pageof 19

Showing results (171-180 of 190) with videos related to

Sort By:
Pageof 19
The Journal of Investigative Dermatology|December 30, 2024
Polygenic Score: A Tool for Evaluating the Genetic Background of Sporadic Hidradenitis SuppurativaChiara Moltrasio, Ronald Moura, Andrea Conti, et al.
Dermatology (Basel, Switzerland)|September 2, 2021
Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of DiseaseGabriella Fabbrocini, Giulia Ruina, Giulia Giovanardi, et al.
Dermatology and Therapy|February 16, 2026
Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis)Emanuele Trovato, Alessandra Cartocci, Francesca Gaiani, et al.
Journal of Clinical Medicine|May 28, 2022
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient WellbeingFrancesca Prignano, Alexandra M G Brunasso, Gabriella Fabbrocini, et al.
Dermatology and Therapy|July 3, 2025
Guselkumab Retention, Effectiveness, and Safety in Psoriasis: A 260-Week Real-World Multicenter Retrospective Study Exploring the Role of Concomitant PsA-IL PSO (Italian Landscape Psoriasis)Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
Journal of Cutaneous Medicine and Surgery|March 17, 2026
Long-Term Outcomes of Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa: A Multicentre Cohort StudyGianluca Avallone, Gabriele Roccuzzo, Luca Valtellini, et al.
Clinical and Experimental Dermatology|November 1, 2025
Cumulative clinical benefits of biologic treatments in patients with moderate-to-severe psoriasis: an Italian real-life experience - IL PSO (Italian Landscape Psoriasis)Diego Orsini, Luca Potestio, Maria Concetta Fargnoli, et al.
Dermatology (Basel, Switzerland)|July 14, 2024
Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert PanelAnnamaria Offidani, Angelo Valerio Marzano, Ketty Peris, et al.
Journal of Clinical Medicine|January 11, 2024
Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe PsoriasisFrancesca Prignano, Giuseppe Argenziano, Federico Bardazzi, et al.
Medicina (Kaunas, Lithuania)|February 26, 2025
High-Frequency and Ultra-High-Frequency Ultrasound in Dermatologic Diseases and Aesthetic MedicineGiulio Argalia, Alfonso Reginelli, Elisa Molinelli, et al.
Pageof 19